2BB score and signals
Olema Pharmaceuticals, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 19 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 48 | Moderate |
Company facts
| Headquarters | San Francisco, California, United States |
| Founded | 2006 |
| Employees | 137 |
| 52-week range | $4.37 – $36.26 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.5714 | — | $0.00 |
| 2026-08-11 | — | -0.5554 | — | $0.00 |
| 2026-05-11 | — | -0.5291 | — | $0.00 |
| 2026-03-02 | — | -0.5393 | — | $0.00 |
2BBBullish & Bearish